Associations between expression of indoleamine 2, 3-dioxygenase enzyme and inflammatory cytokines in patients with first-episode drug-naive Schizophrenia

Abstract The indoleamine 2,3-dioxygenase (IDO) enzyme is the first rate-limiting enzyme of the tryptophan degradation pathway in which dysfunction of neuroactive metabolites has been implicated in the pathophysiology of schizophrenia. Inflammatory molecules such as pro-inflammatory cytokines could e...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Yan Zhang, Han Shi, Ge Yang, Yongfeng Yang, Wenqiang Li, Meng Song, Minglong Shao, Xi Su, Luxian Lv
Formato:	article
Lenguaje:	EN
Publicado:	Nature Publishing Group 2021
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571
Acceso en línea:	https://doaj.org/article/69c12f3f16c542b7a260f3029221cc77
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:69c12f3f16c542b7a260f3029221cc77
record_format	dspace
spelling	oai:doaj.org-article:69c12f3f16c542b7a260f3029221cc772021-11-21T12:07:45ZAssociations between expression of indoleamine 2, 3-dioxygenase enzyme and inflammatory cytokines in patients with first-episode drug-naive Schizophrenia10.1038/s41398-021-01688-x2158-3188https://doaj.org/article/69c12f3f16c542b7a260f3029221cc772021-11-01T00:00:00Zhttps://doi.org/10.1038/s41398-021-01688-xhttps://doaj.org/toc/2158-3188Abstract The indoleamine 2,3-dioxygenase (IDO) enzyme is the first rate-limiting enzyme of the tryptophan degradation pathway in which dysfunction of neuroactive metabolites has been implicated in the pathophysiology of schizophrenia. Inflammatory molecules such as pro-inflammatory cytokines could enhance the activity of IDO. There are few studies on the expression of IDO levels and its correlation with levels of inflammatory cytokines in first-episode drug-naive patients with schizophrenia. One hundred inpatients (female = 33, male = 67) with first-episode drug-naive schizophrenia entered a 6-week, double-blind, randomized, placebo-controlled clinical trial. All individuals were assigned celecoxib or placebo combined with risperidone. Serum levels of IDO and six inflammatory cytokines (IL-1β, IL-6, TNF-α IL-17, IL-4, and INF-γ) were measured. The Positive and Negative Syndrome Scale (PANSS) was used to assess the severity of psychotic symptoms. Compared to healthy subjects, patients had significantly elevated levels of IDO and six cytokines at baseline. Over the 6-week treatment period, the decrease in the levels of IDO and TNF-α and the improvement in the PANSS total score, positive scores, and negative scores in the celecoxib group were significantly greater than in the placebo group. There was a significantly positive correlation between IDO levels and the PANSS negative scores and between IDO levels and TNF-α and IFN-γ levels in the celecoxib group. These findings showed abnormal expression of IDO levels which correlated with negative symptoms and pro-inflammatory cytokine levels in patients with first-episode drug-naive schizophrenia, suggesting the important role of IDO in the pathological mechanism of schizophrenia. Registration number: ChiCTR2000041403.Yan ZhangHan ShiGe YangYongfeng YangWenqiang LiMeng SongMinglong ShaoXi SuLuxian LvNature Publishing GrouparticleNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571ENTranslational Psychiatry, Vol 11, Iss 1, Pp 1-8 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571
spellingShingle	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Yan Zhang Han Shi Ge Yang Yongfeng Yang Wenqiang Li Meng Song Minglong Shao Xi Su Luxian Lv Associations between expression of indoleamine 2, 3-dioxygenase enzyme and inflammatory cytokines in patients with first-episode drug-naive Schizophrenia
description	Abstract The indoleamine 2,3-dioxygenase (IDO) enzyme is the first rate-limiting enzyme of the tryptophan degradation pathway in which dysfunction of neuroactive metabolites has been implicated in the pathophysiology of schizophrenia. Inflammatory molecules such as pro-inflammatory cytokines could enhance the activity of IDO. There are few studies on the expression of IDO levels and its correlation with levels of inflammatory cytokines in first-episode drug-naive patients with schizophrenia. One hundred inpatients (female = 33, male = 67) with first-episode drug-naive schizophrenia entered a 6-week, double-blind, randomized, placebo-controlled clinical trial. All individuals were assigned celecoxib or placebo combined with risperidone. Serum levels of IDO and six inflammatory cytokines (IL-1β, IL-6, TNF-α IL-17, IL-4, and INF-γ) were measured. The Positive and Negative Syndrome Scale (PANSS) was used to assess the severity of psychotic symptoms. Compared to healthy subjects, patients had significantly elevated levels of IDO and six cytokines at baseline. Over the 6-week treatment period, the decrease in the levels of IDO and TNF-α and the improvement in the PANSS total score, positive scores, and negative scores in the celecoxib group were significantly greater than in the placebo group. There was a significantly positive correlation between IDO levels and the PANSS negative scores and between IDO levels and TNF-α and IFN-γ levels in the celecoxib group. These findings showed abnormal expression of IDO levels which correlated with negative symptoms and pro-inflammatory cytokine levels in patients with first-episode drug-naive schizophrenia, suggesting the important role of IDO in the pathological mechanism of schizophrenia. Registration number: ChiCTR2000041403.
format	article
author	Yan Zhang Han Shi Ge Yang Yongfeng Yang Wenqiang Li Meng Song Minglong Shao Xi Su Luxian Lv
author_facet	Yan Zhang Han Shi Ge Yang Yongfeng Yang Wenqiang Li Meng Song Minglong Shao Xi Su Luxian Lv
author_sort	Yan Zhang
title	Associations between expression of indoleamine 2, 3-dioxygenase enzyme and inflammatory cytokines in patients with first-episode drug-naive Schizophrenia
title_short	Associations between expression of indoleamine 2, 3-dioxygenase enzyme and inflammatory cytokines in patients with first-episode drug-naive Schizophrenia
title_full	Associations between expression of indoleamine 2, 3-dioxygenase enzyme and inflammatory cytokines in patients with first-episode drug-naive Schizophrenia
title_fullStr	Associations between expression of indoleamine 2, 3-dioxygenase enzyme and inflammatory cytokines in patients with first-episode drug-naive Schizophrenia
title_full_unstemmed	Associations between expression of indoleamine 2, 3-dioxygenase enzyme and inflammatory cytokines in patients with first-episode drug-naive Schizophrenia
title_sort	associations between expression of indoleamine 2, 3-dioxygenase enzyme and inflammatory cytokines in patients with first-episode drug-naive schizophrenia
publisher	Nature Publishing Group
publishDate	2021
url	https://doaj.org/article/69c12f3f16c542b7a260f3029221cc77
work_keys_str_mv	AT yanzhang associationsbetweenexpressionofindoleamine23dioxygenaseenzymeandinflammatorycytokinesinpatientswithfirstepisodedrugnaiveschizophrenia AT hanshi associationsbetweenexpressionofindoleamine23dioxygenaseenzymeandinflammatorycytokinesinpatientswithfirstepisodedrugnaiveschizophrenia AT geyang associationsbetweenexpressionofindoleamine23dioxygenaseenzymeandinflammatorycytokinesinpatientswithfirstepisodedrugnaiveschizophrenia AT yongfengyang associationsbetweenexpressionofindoleamine23dioxygenaseenzymeandinflammatorycytokinesinpatientswithfirstepisodedrugnaiveschizophrenia AT wenqiangli associationsbetweenexpressionofindoleamine23dioxygenaseenzymeandinflammatorycytokinesinpatientswithfirstepisodedrugnaiveschizophrenia AT mengsong associationsbetweenexpressionofindoleamine23dioxygenaseenzymeandinflammatorycytokinesinpatientswithfirstepisodedrugnaiveschizophrenia AT minglongshao associationsbetweenexpressionofindoleamine23dioxygenaseenzymeandinflammatorycytokinesinpatientswithfirstepisodedrugnaiveschizophrenia AT xisu associationsbetweenexpressionofindoleamine23dioxygenaseenzymeandinflammatorycytokinesinpatientswithfirstepisodedrugnaiveschizophrenia AT luxianlv associationsbetweenexpressionofindoleamine23dioxygenaseenzymeandinflammatorycytokinesinpatientswithfirstepisodedrugnaiveschizophrenia
_version_	1718419191741022208

Associations between expression of indoleamine 2, 3-dioxygenase enzyme and inflammatory cytokines in patients with first-episode drug-naive Schizophrenia

Ejemplares similares